stock decline

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

ImmunityBio faces securities fraud lawsuit after FDA warning letter alleges false Anktiva promotional claims. Stock dropped 21% to $7.42.

Johnson Outdoors delivered strong Q2 results with 16% sales growth and margin expansion, but flagged mounting cost pressures and inventory challenges, causing shares to decline.

MercadoLibre shares fell 11% after Q1 earnings beat revenue expectations but missed profit forecasts, as the company invests heavily in growth. Free cash flow doubled to $1.8B, trading at attractive 7.1x FCF multiple.

$BTBD plummets 35% after-hours following termination of Aero Velocity merger. SEC registration statement failed to become effective by April 30 deadline.

Sportradar stock crashed 22.6% after Muddy Waters alleged illegal gambling connections. Rosen Law Firm investigating for class action lawsuit.

DNOW Inc. shares crashed 19.1% following disappointing Q4 2025 results that missed Wall Street expectations, prompting securities litigation investigation.

NuScale Power's Q1 results disappointed investors with revenue missing estimates by 96% and EPS exceeding losses. Stock fell 6.68% in after-hours trading.

The Trade Desk missed Q1 earnings estimates with $0.28 EPS versus $0.32 expected, triggering a 14.23% after-hours stock decline despite beating revenue guidance.

Uber reported Q1 revenue of $13.2B and beat EPS expectations, but stock declined 3.51% Thursday amid market weakness and risk-off sentiment.

Alpha & Omega Semiconductor shares fell 26.88% despite beating Q3 earnings, as gross margins compressed to 21.1% GAAP, signaling profitability challenges amid revenue growth.

SKK Holdings shares fell 4.28% to $5.38 Thursday after profit-taking following a recent rally, even as the company announced a major $258.8M drone asset acquisition from Rantizo.

Trip.com facing class action lawsuit following 17% stock plunge on antitrust investigation by China's market regulator for alleged monopolistic practices.

FTC sues Zillow and Redfin for alleged anticompetitive rental advertising agreement; class action investigation launched as $Z drops 4.6%.

ADMA Biologics shares fell 24% after withdrawing guidance amid channel stuffing allegations. Block & Leviton investigates potential securities violations affecting multiple companies.

Class action lawsuit filed against $SES AI for alleged securities fraud involving false statements and inflated revenue. Stock crashed 36.8% after disappointing 2026 guidance.

Lucid stock plummeted 74% in a year amid $3.7B losses, $4.8B expenses, and just 16,000 vehicle units produced. Company pursues software revenue and Uber robotaxi partnership to stabilize.

ARK Invest added positions in Shopify, Intellia Therapeutics, and GeneDX after significant stock declines, signaling Wood's conviction in long-term potential despite near-term headwinds.

Trip.com faces securities fraud class action after China's antitrust regulator launches monopoly investigation. Stock fell 19.4% following January announcement.

ImmunityBio faces securities fraud lawsuit after FDA warning letter on Anktiva cancer therapy. Stock plummeted to $7.42. Class action period open through May 26.